Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation.
Context.--Evaluation of estrogen receptor (ER), progesterone receptor (PR), and HER2/neu (HER2) biomarkers is standard of care for all cases of newly diagnosed invasive, recurrent, and metastatic breast cancer. Repeat analysis is also performed in select cases per College of American Pathologists/Am...
| Publicado en: | Archives of Pathology & Laboratory Medicine Vol. 143; no. 12; pp. 1444 - 1450 |
|---|---|
| Autor principal: | |
| Formato: | pictorial review Journal Article |
| Publicado: |
College of American Pathologists
Dec2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |